Avicenna Biosciences, Inc.

CIK 1824034 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avicenna Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Oct 30, 2025D/A0001824034-25-000002
Jul 16, 2024D0001824034-24-000003
Feb 23, 2024D0001824034-24-000001
Mar 22, 2023D/A0001824034-23-000001
Dec 30, 2022D0001824034-22-000002
Oct 27, 2022D0001824034-22-000001
Sep 14, 2020D0001824034-20-000002